Apogee Therapeutics(APGE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

APGE Apogee Therapeutics

Halted 09-23 08:03:27 EDT

135.07

+0.00

0.00%

High135.07	Low135.07	Vol0.00
Open135.07	D1 Closing135.07	Amplitude0.00%
Mkt Cap10.18B	Tradable Cap7.85B	Total Shares75.34M
T/O0.00	T/O Rate0.00%	Tradable Shares58.14M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"APGE","market":"US","secType":"STK","nameCN":"Apogee Therapeutics","latestPrice":135.07,"timestamp":1790107200000,"preClose":135.07,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":58137500,"shares":75339900,"eps":-4.34,"marketStatus":"Halted","change":0,"latestTime":"09-23 08:03:27 EDT","open":135.07,"high":135.07,"low":135.07,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.34,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790170200000},"marketStatusCode":1,"adr":0,"listingDate":1689307200000,"exchange":"NASDAQ","adjPreClose":135.07,"volumeRatio":0},"requestUrl":"/m/hq/s/APGE/wiki","defaultTab":"wiki","newsList":[{"id":"1116146070","title":"AbbVie Closes $10.9B Apogee Deal — Accretion Not Until 2032","url":"https://stock-news.laohu8.com/highlight/detail?id=1116146070","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116146070?lang=en_us&edition=fundamental","pubTime":"2026-09-04 16:12","pubTimestamp":1788509571,"startTime":"0","endTime":"0","summary":"","market":"sg","thumbnail":"https://static.tigerbbs.com/cd390f36a0b47f45f944f34eeb1dc343","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/cd390f36a0b47f45f944f34eeb1dc343"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"AbbVie Closes $10.9B Apogee Deal — Accretion Not Until 2032","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV","APGE"],"isVideo":true,"video":{"duration":160,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/957.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/957.webp","audio_url":"https://static.tigerbbs.com/8e0121fd9702e7b94fab89b7c64df738.mp3","isAI":true},"gpt_icon":0},{"id":"1127014248","title":"AbbVie Closes $10.9B Takeover of Apogee, Its Largest Deal Since 2019, With Earnings Lift Expected From 2032","url":"https://stock-news.laohu8.com/highlight/detail?id=1127014248","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127014248?lang=en_us&edition=fundamental","pubTime":"2026-09-04 09:44","pubTimestamp":1788486257,"startTime":"0","endTime":"0","summary":"AbbVie (NYSE: ABBV) announced on Thursday that it has finalized its $10.9 billion acquisition of inflammation drug developer Apogee Therapeutics (NASDAQ: APGE). This transaction marks the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","LU1496350502.SGD","LU0859254822.USD","IE00B4R5TH58.HKD","LU1923622614.USD","XLV","IE00BLSP4452.SGD","LU0211328371.USD","LU2237443978.SGD","LU0170899867.USD","VHT","LU1162221912.USD","LU2468319806.SGD","LU0689626769.HKD","LU0310799852.SGD","LU1839511570.USD","IE0002270589.USD","JDOC","LU0738911758.USD","LU0820561909.HKD","LU0203345920.USD","IE00B3PB1722.GBP","IE00BVYPNV92.GBP","LU0545039389.USD","CALF","IXJ","LU0553294199.USD","LU1670628061.USD","IE00BJJMRZ35.SGD","LU0882574055.USD","LU0029864427.USD","LU0320765646.SGD","LU0661504455.SGD","LU0128525929.USD","LU0912757837.SGD","LU0943347566.SGD","LU1934455277.USD","IE000WAW04H5.SGD","BK4585","LU0098860793.USD","LU0289739343.SGD","LU2347655073.USD","MEDX","LU0795875169.SGD","LU0861579265.USD","LU1267930573.SGD","LU0256863811.USD","LU1057294990.SGD","LU2237443382.USD","IE00BGHQF631.EUR","LU0289739699.SGD","LU1093756168.USD","LU0965508806.USD","LU0122379950.USD","LU1934455863.HKD","LU2237443895.HKD","LU0456855351.SGD","IE00BBT3K403.USD","LU0053671581.USD","LU1430594728.SGD","IE0000B7K699.USD","SG9999015952.SGD","IE00BN8TJ469.HKD","LU0211327993.USD","LU1983299246.USD","LU0069063385.USD","LU0289961442.SGD","MYLD","IE00B19Z3B42.SGD","LU1496350171.SGD","LU1236620750.USD","LU1074936037.SGD","SG9999015978.USD","PJP","SG9999015945.SGD","LU0823416689.USD","IE00B19Z3581.USD","LU0726765562.USD","BK4534","IE000F7OJYX1.SGD","LU0395794307.EUR","LU0820561818.USD","IE00B42XCP33.USD","SG9999001440.SGD","FHLC","BK4559","SG9999003800.SGD","LU0417517546.SGD","LU1037948897.HKD","LU1093756325.SGD","ABBV","LU1929549753.HKD","BK4581","LU0114720955.EUR","LU0234570918.USD","LU0965509101.SGD","GLAM","LU0868494617.USD","IE000MB6IJN5.SGD","IYH","FTXH","BK4550","LU1003077747.HKD","LU2112291526.USD","LU2347655156.SGD","IE00BSNM7G36.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","IE00B2B36J28.USD","LU2433249047.HKD","LU1551013342.USD","RXL","LU2087621335.USD","LU1585245621.USD","LU1291159041.SGD","LU2125909593.SGD","LU1989771016.USD","LU0472753341.HKD","LU2129689431.USD","KCE","LU0158827948.USD","LU1989772840.SGD","LU0949170772.SGD","LU2237443465.HKD","IE00BLSP4239.USD","PPH","SG9999011175.SGD","LU0965509010.AUD","LU1718418525.SGD","LU1267930490.SGD","IE000SO60NU8.SGD","LU0256863902.USD","SG9999015986.USD","LU1061106388.HKD","LU0689472784.USD","LU1236620834.HKD","BK4533","LU2089283258.USD","LU0708994859.HKD","LU0198837287.USD","LU0965509283.SGD","LU0234572021.USD","BK4588","LU2089284900.SGD","LU1732800096.USD","LU0203347892.USD","LU2133065610.SGD","LU1037948541.HKD","LU2125909247.SGD","IE00BVYPNW00.USD","LU0942090050.USD","LU1023059063.AUD","LU2237443622.USD","LU0511384066.AUD","IE00BJT1NW94.SGD","LU2357627491.SGD","IE0004445239.USD","LU0432979614.USD","LU1244550494.USD","LU2089984988.USD","LU1670627923.USD","LU1732799900.SGD","BK4139","LU0058720904.USD","LU0985320562.USD","LU1244550577.SGD","LU2129689605.HKD","APGE","LU2237443549.SGD","LU0124676726.USD","SBIO","LU1551013425.SGD","LU1989772923.USD","LU0795875086.SGD","LU1244550221.USD","IE000BZT7R73.USD","TRUH","LU2129689514.USD","IE00BDGV0183.EUR","LU1934455194.USD","XMMO","AGNG","LU2023251221.USD","LU0868494708.USD","LU0057025933.USD","LU0310800379.SGD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664080500","title":"Sector Update: Healthcare Stocks Higher Thursday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2664080500","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664080500?lang=en_us&edition=fundamental","pubTime":"2026-09-04 01:49","pubTimestamp":1788457760,"startTime":"0","endTime":"0","summary":"Healthcare stocks were slightly higher Thursday afternoon, with the NYSE Healthcare Index increasing 0.3% and the State Street Health Care Select Sector SPDR ETF  up 0.1%.The iShares Biotechnology ETF  eased 0.3%.In corporate news, Hutchmed  shares jumped 17% after the company said its unit licensed rights to GSK  to develop and commercialize experimental cancer treatment HMPL-A830 outside greater China. GSK shares added 0.8%.AbbVie  said Thursday that it has completed its acquisition of Apogee Therapeutics , valuing the clinical-stage biotechnology company at about $10.9 billion, or $135.11 per share. AbbVie shares were down 0.3%.Ultragenyx Pharmaceutical  shares fell 45% after the firm said a phase 3 study of apazunersen in Angelman syndrome did not achieve the primary endpoint nor a key secondary endpoint.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B4R5TH58.HKD","MEDX","PPH","GLAM","GSK.UK","GSKH","PJP","IE0004445239.USD","LU2237443382.USD","IBB","LU0820561909.HKD","LU1989772923.USD","LU0432979614.USD","LU0708994859.HKD","LU0256863811.USD","BK4137","AGNG","LABU","RXL","HCM","RARE","IYH","LU0029864427.USD","LU1496350171.SGD","JDOC","LU0553294199.USD","LU0114720955.EUR","XLV","LU2125909593.SGD","LU1236620750.USD","LU1244550577.SGD","IXJ","IE00BJJMRZ35.SGD","SBIO","ABBV","LU0124676726.USD","LU0128525929.USD","LU0289961442.SGD","LU0203345920.USD","HCSG","XBI","APGE","BK4534","GSK","IE00BGHQF631.EUR","FHLC","VHT","LU1718418525.SGD","TRUH","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664720938","title":"AbbVie Closes $10.9 Billion Acquisition of Apogee Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2664720938","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664720938?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:13","pubTimestamp":1788441193,"startTime":"0","endTime":"0","summary":"AbbVie  said Thursday that it has completed its acquisition of Apogee Therapeutics , valuing the clinical-stage biotechnology company at about $10.9 billion, or $135.11 per share.The acquisition is expected to negatively impact adjusted diluted earnings per share by $0.14 in 2026 and by approximately $0.46 in 2027, with accretion beginning in 2032, AbbVie said.Apogee Therapeutics' stock ceased trading on the Nasdaq stock exchange prior to the market open on Sept. 3, according to a statement.AbbVie said it continues to expect Q3 adjusted diluted EPS in the range of $3.84 to $3.88, and full-year adjusted diluted EPS between $13.87 to $14.07.Analysts polled by FactSet expect $3.86 and $14.03, respectively.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PJP","ABBV","IXJ","APGE","LU1037948897.HKD","LU1093756325.SGD","VHT","FTXH","LU0965509101.SGD","PPH","RXL","IE00BVYPNV92.GBP","LU0795875169.SGD","FHLC","LU2125909247.SGD","LU0985320562.USD","LU0289739343.SGD","IE00BJJMRZ35.SGD","LU1023059063.AUD","IYH","LU2237443382.USD","AGNG","LU2129689514.USD","LU0795875086.SGD","GLAM","LU0289961442.SGD","LU2089283258.USD","LU1244550494.USD","LU2237443622.USD","LU0069063385.USD","LU0456855351.SGD","SBIO","LU0320765646.SGD","IE00B19Z3B42.SGD","LU0057025933.USD","LU1061106388.HKD","LU1267930573.SGD","LU0965509010.AUD","JDOC","LU0417517546.SGD","IE00BBT3K403.USD","LU0949170772.SGD","SG9999011175.SGD","LU1923622614.USD","XLV","MEDX","LU0738911758.USD","TRUH","LU0432979614.USD","LU0310799852.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664872503","title":"Apogee Therapeutics Shares Face NASDAQ Suspension as Company Moves to Delist After AbbVie Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2664872503","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664872503?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:54","pubTimestamp":1788440071,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics shares face Nasdaq suspension as company moves to delist after AbbVie mergerApogee notified Nasdaq of its merger close, requesting delisting and continued trading halt; shares suspended from trading Sept. 4, 2026.Nasdaq to file SEC Form 25 to delist and deregister the stock under Exchange Act Section 12.Company plans to file SEC Form 15 to terminate registration under Section 12, suspending reporting obligations under Sections 13 and 15.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apogee Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 03, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL3D254h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2347655156.SGD","LU2468319806.SGD","IXJ","LU2133065610.SGD","IYH","PPH","TRUH","LU0882574055.USD","LU0965508806.USD","IE00B4R5TH58.HKD","IE000F7OJYX1.SGD","LU1023059063.AUD","VHT","APGE","LU2112291526.USD","IE00B3PB1722.GBP","LU0965509010.AUD","LU1989771016.USD","LU2089284900.SGD","MEDX","SBIO","LU0320765646.SGD","LU2237443895.HKD","XLV","FHLC","FTXH","LU1934455277.USD","GLAM","JDOC","BK4534","AGNG","IE000MB6IJN5.SGD","LU1670627923.USD","LU0943347566.SGD","RXL","ABBV","SG9999003800.SGD","IE00B19Z3581.USD","LU2347655073.USD","LU0985320562.USD","PJP","LU1061106388.HKD","LU0820561909.HKD","LU0868494708.USD","LU2237443382.USD","IE00BJJMRZ35.SGD","IE00BN8TJ469.HKD","LU2237443549.SGD","LU0128525929.USD","LU2129689514.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664874750","title":"Abbvie Completes Acquisition of Apogee Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2664874750","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664874750?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:35","pubTimestamp":1788438900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA5XSP4L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0098860793.USD","BK4139","IXJ","LU1496350171.SGD","LU2112291526.USD","IE000MB6IJN5.SGD","LU2237443465.HKD","PPH","RXL","TRUH","LU0985320562.USD","GLAM","SG9999015978.USD","SG9999011175.SGD","LU1839511570.USD","BK4581","LU0158827948.USD","APGE","IE000F7OJYX1.SGD","LU1989772840.SGD","LU2237443978.SGD","IE00B19Z3581.USD","IE0002141913.USD","JDOC","FTXH","MEDX","LU0057025933.USD","LU0726765562.USD","LU0795875086.SGD","AGNG","BK4566","LU0912757837.SGD","LU0289739343.SGD","SBIO","IYH","LU0511384066.AUD","IE0004445239.USD","ABBV","BK4559","LU2087621335.USD","LU1037948541.HKD","LU1291159041.SGD","FHLC","LU1934455863.HKD","PJP","VHT","LU0820561818.USD","LU2089283258.USD","XLV","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664787475","title":"Abbvie - Reaffirms 2026 Q3 Adj Diluted EPS Guidance $3.84-$3.88","url":"https://stock-news.laohu8.com/highlight/detail?id=2664787475","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664787475?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:35","pubTimestamp":1788438900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA5XSP4L:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDX","LU1551013342.USD","XLV","LU0098860793.USD","LU0203347892.USD","IE00B3PB1722.GBP","APGE","BK4534","FHLC","LU1236620834.HKD","LU1929549753.HKD","FTXH","LU0965509101.SGD","LU1983299246.USD","JDOC","RXL","GLAM","BK4588","IE00BJJMRZ35.SGD","LU0128525929.USD","LU1057294990.SGD","IYH","LU0726765562.USD","LU0029864427.USD","LU1003077747.HKD","PJP","IXJ","LU2087621335.USD","IE00BBT3K403.USD","LU0114720955.EUR","TRUH","LU0689626769.HKD","SBIO","PPH","LU0234572021.USD","BK4581","LU1244550494.USD","LU1670627923.USD","LU0053671581.USD","LU0456855351.SGD","BK4585","LU0965508806.USD","LU0511384066.AUD","LU2023251221.USD","ABBV","SG9999015952.SGD","VHT","AGNG","LU1934455194.USD","LU1718418525.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664421938","title":"NASDAQ Trade Halt Trading Halted; for Information Requested by NASDAQ at 07:50 Pm","url":"https://stock-news.laohu8.com/highlight/detail?id=2664421938","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664421938?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:50","pubTimestamp":1788393000,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTTRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nAQN2MHUGD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","SBIO","BK4139","APGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660492377","title":"AbbVie Closes USD 10B Multi-Tranche Senior Notes Offering to Fund Apogee Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492377","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492377?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:31","pubTimestamp":1787085094,"startTime":"0","endTime":"0","summary":"AbbVie closes USD 10B multi-tranche senior notes offering to fund Apogee dealAbbVie completed a USD 10 billion senior notes offering, including senior floating rate notes due 2028.Deal included fixed-rate senior notes across eight maturities from 2028 to 2066, with coupons from 4.5% to 6.1%.Proceeds earmarked to fund part of the cash consideration for AbbVie’s planned acquisition of Apogee Therapeutics.If the Apogee deal is terminated, AbbVie must redeem the floating-rate notes and fixed-rate notes due 2028-2038 at 101%.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AbbVie Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Se","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDLbzVC04:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203347892.USD","GLAM","IE000BZT7R73.USD","FHLC","LU0417517546.SGD","LU2433249047.HKD","BK4534","LU0128525929.USD","LU1718418525.SGD","LU0545039389.USD","IE00BSNM7G36.USD","SBIO","MEDX","LU0395794307.EUR","LU0211328371.USD","IE000SO60NU8.SGD","IE00B19Z3581.USD","IE00B4R5TH58.HKD","PPH","LU2125909593.SGD","LU2129689605.HKD","PJP","LU0472753341.HKD","LU0708994859.HKD","LU1093756325.SGD","APGE","LU2237443549.SGD","ABBV","FTXH","VHT","LU0234572021.USD","LU0795875086.SGD","RXL","LU0965509283.SGD","LU1989771016.USD","LU0256863811.USD","AGNG","IYH","JDOC","XLV","BK4533","SG9999001440.SGD","LU0553294199.USD","LU0310799852.SGD","LU2237443622.USD","LU0965508806.USD","LU0114720955.EUR","IXJ","LU1839511570.USD","TRUH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659166348","title":"Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and Biogen (BIIB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659166348","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659166348?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:00","pubTimestamp":1786636814,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Apogee Therapeutics (APGE) and Biogen (BIIB). Apog...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-apogee-therapeutics-apge-and-biogen-biib-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-apogee-therapeutics-apge-and-biogen-biib-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z9P08.USD","IE00B894F039.SGD","XLV","LABU","LU0029874061.USD","BK4139","PBE","BIIB","BK4581","BK4137","HCSG","LU0109394709.USD","LU0234570918.USD","BK4588","APGE","BK4533","BMED","LU0320765992.SGD","IE00B19Z9Z06.USD","LU0128526141.USD","LU0889565916.HKD","BK4585","BK4532","SBIO","LU0053671581.USD","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659139535","title":"U.S. Research Roundup-Airbnb, Five Below, Silgan Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2659139535","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659139535?lang=en_us&edition=fundamental","pubTime":"2026-08-13 14:48","pubTimestamp":1786603733,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan HoldingsAug 13 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Airbnb, Fi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL4N44A0G6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COHH","AX","DFTX","COHC","AIQ","APA","BGS","ANRO","ACM","CSCO","MLPI","CAH","SPRX","ARXS","AIZ","APGE","AMTM","AKAM","AMWL","GASZ","LNG","ANDG","ALL","AMRZ","ARMK","CRWV","AHR","CRGY","BESF","AADX","BBY","CORD","CSV","CRWG","DVN","AOSL","COHR","BTGO","EAT","ALGM","COHX","ACH","CC","PKB","CBRS","ABNB","ATO","CYTK","CHRD","PXI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658869974","title":"BTIG Downgrades Apogee Therapeutics to Neutral From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2658869974","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658869974?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:23","pubTimestamp":1786533826,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics (APGE) has an average rating of hold and mean price target of $132.44, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["APGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658979608","title":"Apogee Therapeutics, Inc. : Btig Cuts to Neutral from Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2658979608","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658979608?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:43","pubTimestamp":1786531419,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4490DF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SBIO","APGE","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658979902","title":"Apogee Therapeutics Cut to Neutral from Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2658979902","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658979902?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:39","pubTimestamp":1786531140,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/APGE/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658947798","title":"RBC Capital Sticks to Their Hold Rating for Apogee Therapeutics (APGE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658947798","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658947798?lang=en_us&edition=fundamental","pubTime":"2026-08-12 09:45","pubTimestamp":1786499140,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Brian Abrahams maintained a Hold rating on Apogee Therapeutics on August 10 and set a price target of $135.00. The company’s sh...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-hold-rating-for-apogee-therapeutics-apge-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-hold-rating-for-apogee-therapeutics-apge-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658948566","title":"Apogee Therapeutics Gelar Rapat Khusus Pemegang Saham Lewat Webcast Langsung","url":"https://stock-news.laohu8.com/highlight/detail?id=2658948566","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658948566?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:03","pubTimestamp":1786478583,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics gelar rapat khusus pemegang saham lewat webcast langsungApogee Therapeutics menggelar rapat khusus pemegang saham pada 11 Agustus 2026 untuk membahas transaksi merger yang diusulka","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDLRjqrs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXL","LU2347655073.USD","IE00B3PB1722.GBP","LU0256863902.USD","IE00BGHQF631.EUR","LU1670627923.USD","LU1496350502.SGD","MEDX","IYH","PJP","IE00B42XCP33.USD","IE00BVYPNW00.USD","LU0114720955.EUR","LU1003077747.HKD","LU0289961442.SGD","LU1244550221.USD","IE0009355771.USD","LU0234572021.USD","LU0124676726.USD","GLAM","IXJ","VHT","LU0053671581.USD","LU1162221912.USD","SBIO","LU2129689605.HKD","BK4581","PPH","AGNG","IE000MB6IJN5.SGD","APGE","TRUH","LU0256863811.USD","LU2237443465.HKD","LU0158827948.USD","FHLC","FTXH","LU0310800379.SGD","LU0395794307.EUR","LU0949170772.SGD","XLV","ABBV","IE000SO60NU8.SGD","JDOC","IE00B2B36J28.USD","IE000F7OJYX1.SGD","SG9999003800.SGD","IE00BSNM7G36.USD","LU0689472784.USD","LU0417517546.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658433917","title":"Analysts Offer Insights on Healthcare Companies: Relmada Therapeutics (RLMD), Surgery Partners (SGRY) and Apogee Therapeutics (APGE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658433917","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658433917?lang=en_us&edition=fundamental","pubTime":"2026-08-12 02:10","pubTimestamp":1786471809,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Relmada Therapeutics (RLMD), Surgery Partners (SGRY) and Apogee T...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-relmada-therapeutics-rlmd-surgery-partners-sgry-and-apogee-therapeutics-apge-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-relmada-therapeutics-rlmd-surgery-partners-sgry-and-apogee-therapeutics-apge-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","SBIO","PSIL","BK4585","LU0128526141.USD","APGE","RLMD","SGRY","XBI","LU0053671581.USD","HCSG","XLV","LU0029874061.USD","BK4137","BK4185","BK4588","BK4007","BK4581","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658916683","title":"Wedbush Reaffirms Their Hold Rating on Apogee Therapeutics (APGE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658916683","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658916683?lang=en_us&edition=fundamental","pubTime":"2026-08-11 21:55","pubTimestamp":1786456517,"startTime":"0","endTime":"0","summary":"Wedbush analyst David Nierengarten maintained a Hold rating on Apogee Therapeutics today and set a price target of $135.00. Nierengarten covers the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wedbush-reaffirms-their-hold-rating-on-apogee-therapeutics-apge-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wedbush-reaffirms-their-hold-rating-on-apogee-therapeutics-apge-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658625839","title":"Apogee Therapeutics’ Merger Faces Significant Execution Risks, Potential $381 Million Termination Fee and Stock Price Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=2658625839","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658625839?lang=en_us&edition=fundamental","pubTime":"2026-08-11 14:00","pubTimestamp":1786428020,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics, Inc. (APGE) has disclosed a new risk, in the Corporate Activity and Growth category. Apogee Therapeutics, Inc. faces execution...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/apogee-therapeutics-merger-faces-significant-execution-risks-potential-381-million-termination-fee-and-stock-price-pressure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/apogee-therapeutics-merger-faces-significant-execution-risks-potential-381-million-termination-fee-and-stock-price-pressure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU0053671581.USD","APGE","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658933347","title":"Apogee Therapeutics Q2 EPS $(1.14) Misses $(1.05) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2658933347","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658933347?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:22","pubTimestamp":1786360965,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics (NASDAQ:APGE) reported quarterly losses of $(1.14) per share which missed the analyst consensus estimate of $(1.05) by 8.57 percent. This is a 0.88 percent decrease over losses of $(1.13) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61070144/apogee-therapeutics-q2-eps-1-14-misses-1-05-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APGE"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.apogeetherapeutics.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.0024},{"period":"3month","weight":0.0179},{"period":"6month","weight":0.7224},{"period":"1year","weight":2.5582},{"period":"ytd","weight":0.7895}],"compareEarnings":[{"period":"1week","weight":0.0211},{"period":"1month","weight":0.01},{"period":"3month","weight":0.0547},{"period":"6month","weight":0.1989},{"period":"1year","weight":0.1598},{"period":"ytd","weight":0.1341}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.006689},{"month":2,"riseRate":0.666667,"avgChangeRate":-0.043968},{"month":3,"riseRate":1,"avgChangeRate":0.433037},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.069219},{"month":5,"riseRate":0,"avgChangeRate":-0.056063},{"month":6,"riseRate":0.666667,"avgChangeRate":0.221133},{"month":7,"riseRate":0.666667,"avgChangeRate":0.042938},{"month":8,"riseRate":0.75,"avgChangeRate":0.020167},{"month":9,"riseRate":0.5,"avgChangeRate":0.042189},{"month":10,"riseRate":0.333333,"avgChangeRate":0.038958},{"month":11,"riseRate":0.666667,"avgChangeRate":0.091668},{"month":12,"riseRate":1,"avgChangeRate":0.161393}],"exchange":"NASDAQ","name":"Apogee Therapeutics","nameEN":"Apogee Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Apogee Therapeutics(APGE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Apogee Therapeutics(APGE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Apogee Therapeutics,APGE,Apogee Therapeutics股票,Apogee Therapeutics股票老虎,Apogee Therapeutics股票老虎国际,Apogee Therapeutics行情,Apogee Therapeutics股票行情,Apogee Therapeutics股价,Apogee Therapeutics股市,Apogee Therapeutics股票价格,Apogee Therapeutics股票交易,Apogee Therapeutics股票购买,Apogee Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Apogee Therapeutics(APGE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Apogee Therapeutics(APGE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}